Article Details

New Data Reinforce Safety Profile of Emicizumab in Patients with Hemophilia A

Retrieved on: 2021-07-20 18:22:30

Tags for this article:

Click the tags to see associated articles and topics

New Data Reinforce Safety Profile of Emicizumab in Patients with Hemophilia A. View article details on hiswai:

Excerpt

A final analysis of data from the phase 3b STASEY study supports the benefit and risk profile of emicizumab (Hemlibra) in patients with hemophilia A, ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up